Stay updated with breaking news from Cap Media Relations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulatory News: Hoffmann Green Cement Technologies (ISIN: FR0013451044, Ticker: ALHGR) (Paris:ALHGR) ("Hoffmann Green Cement" or the "Company"), an industrial player committed to decarbonizing the
The First In Human implantation of the ICOMS FLOWMAKER is assured following this financing FineHeart S.A, a preclinical medical device company that has developed theICOMS FLOWMAKER, an Implantable
FineHeart S.A: FineHeart Breaks New Ground With Successful Removal of the ICOMS FLOWMAKER in a 90-day In-vivo Trial Easy removal with a beating heart without damage to the myocardium 30 days after implantation Normal heart functioning 60 days after explantation Completely sealed operation with dedicated implant fixation system Quick recovery and short hospital stay Autonomy and free from complications or infection, or structural damage to the heart and vital organs FineHeart S.A a preclinical medical device company that has developed the ICOMS FLOWMAKER, an Implantable Cardiac Output Managem...